Brand: ProteoGenix

Bimekizumab Biosimilar – Anti-IL17A, IL17F mAb – Research Grade

PX-TA1342-100UG
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: IgG1, kappa

$238.00

100ug + 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb binds to IL17A, C-His, recombinant protein in indirect ELISA Assay

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade

Product name	Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade
Source	CAS 1418205-77-2
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Bimekizumab,CDP4940,IL17A, IL17F,anti-IL17A, IL17F
Reference	PX-TA1342
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

Product name	Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade
Source	CAS 1418205-77-2
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Bimekizumab,CDP4940,IL17A, IL17F,anti-IL17A, IL17F
Reference	PX-TA1342
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

General information on Anti-IL17A[Homo sapiens] (Bimekizumab) Monoclonal Antibody

Bimekizumab has beeninvestigated for the treatment of Psoriatic arthritis, Ankylosing Spondylitis, Chronic Plaque Psoriasis, and Mild to Moderate Psoriasis.

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb binds to IL17A, C-His, recombinant protein in indirect ELISA Assay

Immobilized IL17A, C-His, recombinant protein (cat. No.PX-P5780) at 0.5µg/mL (100µL/well) can bind to Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb (cat. No.PX-TA1342) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Bimekizumab Biosimilar – Anti-IL17A, IL17F mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Bimekizumab Biosimilar – Anti-IL17A, IL17F mAb – Research Grade

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade

General information on Anti-IL17A[Homo sapiens] (Bimekizumab) Monoclonal Antibody

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb binds to IL17A, C-His, recombinant protein in indirect ELISA Assay

Related products

Interleukin-17A(IL17A)

IL17A, C-His, recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Bimekizumab ELISA Kit

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Bimekizumab Biosimilar – Anti-IL17A, IL17F mAb – Research Grade

Specifications Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade

Description

General information on Anti-IL17A[Homo sapiens] (Bimekizumab) Monoclonal Antibody

Documents

QC & Validation

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb binds to IL17A, C-His, recombinant protein in indirect ELISA Assay

Reviews

Related products

Interleukin-17A(IL17A)

IL17A, C-His, recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Bimekizumab ELISA Kit

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade